Dr. Gerasimowicz is currently Chairman and CEO of Meditron Asset Management, LLC., a private equity and high-net-worth investor management firm. Until recently he headed Lehman Brothers Advisory Services and was Chief Investment Strategist for high-net-worth investors in Lehman' Private Client Services Division. As a Senior Vice-President he was responsible for portfolio allocation, construction, rebalancing, risk-management and performance attribution. Prior to Lehman Brothers, Dr. Gerasimowicz was Head of the International Portfolio Advisory Group at J. P. Morgan where he pioneered state of the art risk management techniques. Before joining J.P Morgan he worked as a Senior Scientist for the USDA, and the Naval Research Laboratories (NLR) in Washington, D.C. where he specialized in multiple-quantum nuclear magnetic resonance and solid-state thermodynamic research. Dr. Gerasimowicz has B.S. in Chemistry from Ursinus College, MS and Ph. D degrees in Physical Chemistry from Villanova University and an MBA in Finance from Wharton School of the University of Pennsylvania.
If you are interested in learning more about TIGER 21, please complete the contact form and you will receive a copy of our most recent Asset Allocation Report.